ACTIVE

E & A FARMA

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

179,1 k €

-8.3% YoY

Gross margin

637,1 k €

+19.3% YoY

Equity

1,2 M €

+3.0% YoY

Workforce

4,8 ETP

+20.0% YoY

What does E & A FARMA do?

E & A FARMA is a Private limited company incorporated in 2002. Its main activity is: Activities of holding companies. Its registered office is in Tervuren. It employs on average 4,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0477.349.371

Incorporation

16/04/2002

Legal form

Private limited company

Registered office

Lindenberg 16
3080 Tervuren · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/03/2025

Average workforce

4,8 ETP

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies 74151Specialised design activities

Joint committees (2)

200
2000

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	637,1 k €	+19.3%	534,2 k €	-0.1%	535 k €	-8.4%	583,8 k €	+7.4%	543,5 k €	+38.8%	391,5 k €	+47.3%	265,8 k €	+20.9%	219,9 k €	+57.2%	139,9 k €	-5.1%	147,4 k €	-25.5%	197,9 k €	+17.8%	168,1 k €	+8.1%	155,5 k €	-36.3%	244 k €	+1.2%	241,1 k €	+8.6%	222,1 k €	-0.3%	222,7 k €	+79.3%	124,2 k €	+14.2%	108,8 k €
EBITDA	302,1 k €	-6.3%	322,5 k €	+2.0%	316,3 k €	-15.9%	376,1 k €	+1.6%	370 k €	+41.9%	260,8 k €	+13.6%	229,5 k €	+10.1%	208,5 k €	+61.6%	129 k €	-7.2%	139 k €	-25.7%	187,2 k €	+18.8%	157,6 k €	+5.0%	150 k €	-22.0%	192,3 k €	+20.6%	159,5 k €	+3.1%	154,8 k €	-9.0%	170,1 k €	+60.8%	105,8 k €	+2.8%	102,9 k €
Operating result	273,8 k €	-7.9%	297,3 k €	+1.5%	292,9 k €	-15.3%	345,7 k €	+2.1%	338,5 k €	+47.2%	229,9 k €	+16.4%	197,5 k €	+11.4%	177,2 k €	+76.6%	100,3 k €	-9.5%	110,9 k €	-29.1%	156,3 k €	+70.8%	91,5 k €	-25.8%	123,2 k €	+2.8%	119,9 k €	+20.3%	99,7 k €	+11.6%	89,3 k €	-13.2%	102,9 k €	+160%	39,6 k €	-50.6%	80,2 k €
Net result	179,1 k €	-8.3%	195,4 k €	+0.4%	194,6 k €	-17.3%	235,3 k €	+2.0%	230,6 k €	+53.6%	150,1 k €	+17.6%	127,7 k €	+20.6%	105,9 k €	+99.0%	53,2 k €	+44.5%	36,8 k €	-58.9%	89,7 k €	+60.6%	55,8 k €	-90.6%	593 k €	+1077%	50,4 k €	+13.4%	44,4 k €	+71.5%	25,9 k €	-53.3%	55,5 k €	+973%	-6,4 k €	-122%	29,5 k €
Balance sheet
Equity	1,2 M €	+3.0%	1,1 M €	-9.3%	1,3 M €	+6.7%	1,2 M €	+10.5%	1,1 M €	-10.0%	1,2 M €	+4.8%	1,1 M €	+12.3%	1 M €	+11.7%	902,8 k €	+6.3%	849,6 k €	+4.5%	812,8 k €	+12.4%	723,2 k €	+8.4%	667,4 k €	+797%	74,4 k €	-1.5%	75,5 k €	+23.7%	61 k €	+14.9%	53,1 k €	+57.8%	33,7 k €	-15.9%	40 k €
Total assets	1,7 M €	+6.3%	1,6 M €	+0.2%	1,5 M €	+4.0%	1,5 M €	-8.4%	1,6 M €	+6.5%	1,5 M €	+9.1%	1,4 M €	+2.7%	1,4 M €	+4.1%	1,3 M €	-1.2%	1,3 M €	-10.1%	1,5 M €	+4.7%	1,4 M €	+9.5%	1,3 M €	+31.6%	976 k €	-12.7%	1,1 M €	-4.4%	1,2 M €	-3.0%	1,2 M €	+0.7%	1,2 M €	+30.1%	920,2 k €
Cash	171,3 k €	+3.3%	165,8 k €	-3.3%	171,5 k €	+48.2%	115,8 k €	-63.9%	320,7 k €	+119%	146,5 k €	+8.8%	134,6 k €	+189%	46,6 k €	-25.4%	62,6 k €	+41.9%	44,1 k €	+3.4%	42,6 k €	+119%	19,5 k €	-32.1%	28,7 k €	-30.4%	41,3 k €	-42.1%	71,2 k €	+241%	20,9 k €	-50.2%	42 k €	+258%	11,7 k €	+65.2%	7,1 k €
Debts	473,4 k €	+15.5%	410 k €	+42.1%	288,5 k €	-6.2%	307,6 k €	-44.8%	556,9 k €	+64.2%	339 k €	+31.5%	257,9 k €	-25.2%	345 k €	-13.2%	397,6 k €	-14.6%	465,7 k €	-28.7%	653,4 k €	-3.7%	678,3 k €	+11.7%	607,1 k €	-32.4%	897,9 k €	-13.7%	1 M €	-6.0%	1,1 M €	-3.8%	1,1 M €	-1.0%	1,2 M €	+32.4%	877 k €
Other
Workforce	4,8 ETP	+20.0%	4,0 ETP	+17.6%	3,4 ETP	+13.3%	3,0 ETP	+30.4%	2,3 ETP	0.0%	2,3 ETP	+229%	0,7 ETP	+600%	0,1 ETP	0.0%	0,1 ETP	0.0%	0,1 ETP	0.0%	0,1 ETP		–		–		1,0 ETP	-9.1%	1,1 ETP	-8.3%	1,2 ETP	+20.0%	1,0 ETP	0.0%	1,0 ETP		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 4 active · 2 ended

Active mandates

Inge Annaert

Director

Active

Johan Eykens

Director

Active

Lies Eykens

Director

Active

Tim Eykens

Director

Active

Ended mandates

Inge Annaert

Manager

Ended

Johan Eykens

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
JOIN PHARMA● Active	0846.679.346

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019
Closing of the financial year	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/09/2025	30/09/2024	31/10/2023	10/10/2022	12/10/2021	04/09/2020
General meeting	12/09/2025	24/09/2024	15/09/2023	30/09/2022	30/09/2021	28/08/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/03/2025	12/09/2025	30/09/2025	Dutch	PDF
Abridged model	31/03/2024	24/09/2024	30/09/2024	Dutch	PDF
Abridged model	31/03/2023	15/09/2023	31/10/2023	Dutch	PDF
Abridged model	31/03/2022	30/09/2022	10/10/2022	Dutch	PDF
Abridged model	31/03/2021	30/09/2021	12/10/2021	Dutch	PDF
Abridged model	31/03/2020	28/08/2020	04/09/2020	Dutch	PDF
Abridged model	31/03/2019	23/08/2019	19/09/2019	Dutch	PDF
Abridged model	31/03/2018	24/08/2018	20/09/2018	Dutch	PDF
Abridged model	31/03/2017	25/08/2017	22/09/2017	Dutch	PDF
Abridged model	31/03/2016	26/08/2016	30/08/2016	Dutch	PDF
Abridged model	31/03/2015	28/08/2015	25/09/2015	Dutch	PDF
Abridged model	31/03/2014	22/08/2014	18/09/2014	Dutch	PDF
Abridged model	31/03/2013	23/08/2013	29/10/2013	Dutch	PDF
Abridged model	31/03/2012	24/08/2012	14/12/2012	Dutch	PDF
Abridged model	31/03/2011	26/08/2011	23/11/2011	Dutch	PDF
Abridged model	31/03/2010	27/08/2010	30/09/2010	Dutch	PDF
Abridged model	31/03/2009	28/08/2009	30/10/2009	Dutch	PDF
Abridged model	31/03/2008	22/08/2008	28/11/2008	Dutch	PDF
Abridged model	31/03/2007	24/08/2007	15/10/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 4 active · 2 ended

Active mandates

Inge Annaert

Director

Active

Johan Eykens

Director

Active

Lies Eykens

Director

Active

Tim Eykens

Director

Active

Ended mandates

Inge Annaert

Manager

Ended

Johan Eykens

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring24/10/2025
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring19/06/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates01/03/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/01/2022
ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates05/03/2020
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Other10/04/2014
DOEL
PDF
Other02/01/2003
DIVERSEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025179,1 k €↓
2024
Annual accounts 2024195,4 k €↑
2023
Annual accounts 2023194,6 k €↓
2022
Annual accounts 2022235,3 k €↑
2021
Annual accounts 2021230,6 k €↑
2020
Annual accounts 2020150,1 k €↑
2019
Annual accounts 2019127,7 k €↑
2018
Annual accounts 2018105,9 k €↑
2017
Annual accounts 201753,2 k €↑
2016
Annual accounts 201636,8 k €↓
2015
Annual accounts 201589,7 k €↑
2014
Annual accounts 201455,8 k €↓
2013
Annual accounts 2013593 k €↑
2012
Annual accounts 201250,4 k €↑
2011
Annual accounts 201144,4 k €↑
2010
Annual accounts 201025,9 k €↓
2009
Annual accounts 200955,5 k €↑
2008
Annual accounts 2008-6,4 k €↓
2007
Annual accounts 200729,5 k €
16/04/2002
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

E & A FARMA

Overview

What does E & A FARMA do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline